摘要
目的：分析葛根素和奥扎格雷钠治疗缺血性脑血管疾病的临床疗效。方法回顾分析2012年12月～2014年12月本院89例缺血性脑血管疾病患者临床资料，按不同治疗方案分为两组，对照组43例行葛根素治疗，研究组46例在其基础上行奥扎格雷钠治疗，观察两组疗效及神经缺损评分。结果对照组总有效率（79.1%）低于研究组（95.7%），且神经缺损评分高于研究组，差异均具统计学意义（P＜0.05）。结论葛根素和奥扎格雷钠治疗缺血性脑血管疾病的临床疗效显著。
ObjectiveThe clinical efficacy of ischemic cerebrovascular disease and ozagrel analysis puerarin treatment.MethodsRetrospective analysis of December 2012 -2014 December clinical data of 89 cases of hospital patients with ischemic cerebrovascular disease, according to the different treatment options are divided into two groups, a control group of 43 routine puerarin treatment, study group of 46 patients at its base uplink ozagrel treatment were observed efficacy and neurological deficit score. ResultsThe control group, the total efifciency of 79.1% is lower than the study group was 95.7%, and the neurological deficit scores higher than the study group, the differences were statistically significant （p〈0.05）. ConclusionThe clinical efficacy of puerarin and ozagrel treatment of ischemic cerebrovascular disease signiifcantly.
出处
《中国继续医学教育》
2015年第12期204-205,共2页
China Continuing Medical Education
